#USA #Chicago #Black Buffalo #Sanova #smokeless tobacco

Black Buffalo Inc. Collaborates with Sanova, LLC

On December 16, 2025, Black Buffalo Inc., known for its modern alternatives to traditional smokeless tobacco, announced a partnership with Sanova, LLC, a recognized scientific and regulatory consulting agency. This collaboration aims to enhance Black Buffalo’s regulatory and compliance strategies while advancing its scientific research programs.

Sanova brings a wealth of experience to the table, particularly in aiding nicotine manufacturers navigate the complexities of regulatory frameworks, such as the U.S. Food and Drug Administration's (FDA) Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) pathways. With this partnership, Black Buffalo is well-positioned to navigate essential review phases of FDA protocols, focusing on a thorough scientific review process that assesses health impact and safety of nicotine products intended for adult consumers.

Kellsi Booth, Chief Legal Officer of Black Buffalo, highlighted the importance of Sanova’s expertise, stating, “The Sanova team combines decades of FDA and industry insight with a forward-looking approach. Enlisting Sanova as a partner demonstrates our commitment to regulatory transparency, scientific excellence, and responsible innovation in the nicotine sector.”

Sanova's role includes the design and execution of both non-clinical and clinical studies, collaborating with third-party research partners to produce comprehensive data packages. This systematic approach has proven successful for Sanova as it assists various companies in illustrating that their innovative products meet the FDA's strict criteria for safeguarding public health, thus allowing them to navigate an evolving regulatory environment with assurance.

Sarah Marking, Chief Strategy Officer of Sanova, expressed enthusiasm about collaborating with Black Buffalo, emphasizing the novel product formats developed by the company. “Black Buffalo's unique offerings present potential consumer benefits and distinct regulatory challenges, which we are prepared to address through meticulously designed scientific studies and continuous engagement with the FDA.”

An important aspect of Black Buffalo’s mission revolves around delivering a fulfilling, ritualistic dip experience free from tobacco leaf or stem. The products are tailored for adult consumers (21+) who are current users of nicotine or tobacco products. As Black Buffalo continues to make strides in the smokeless alternatives market, maintaining compliance and innovation, Sanova will provide crucial support to ensure alignment with the highest scientific and regulatory standards.

About Black Buffalo

Founded in 2015, Black Buffalo has earned its reputation as America's leading alternative to traditional smokeless tobacco, dedicating over 25,000 hours to research and development. The company has consistently ranked among the Inc. 5000 Fastest-Growing Private Companies in America, receiving accolades for its outstanding new product innovations within the convenience trade.

Black Buffalo’s smokeless tobacco alternatives are available both in physical stores and online. For more information about Black Buffalo or to locate products in nearby retailers, consumers can visit the company’s official website. Retailers interested in partnering with Black Buffalo are encouraged to reach out via email.

It’s important to note that certain products offered by Black Buffalo contain pharmaceutical-grade, tobacco-derived nicotine, which is recognized as an addictive chemical, and are intended solely for adult consumers aged 21 and older who currently use nicotine or tobacco products.

About Sanova

Sanova is a consultancy firm specializing in scientific and regulatory affairs, focusing on the nicotine and pharmaceutical sectors. The company assists organizations in designing, managing, and interpreting studies that support FDA submissions and public communications. Sanova has a successful track record in securing PMTAs and MRTPs for some of the industry's most established brands, facilitating essential regulatory and scientific initiatives.